TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety Study of Bevacizumab Plus Chemotherapy in EGFR-TKI Resistant Non-Squamous Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy of a Bevacizumab Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- N/A
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
FMISO PET Study of Glioblastoma
- Status
- COMPLETED
- Phase
- NA
Angiogenic Factor Expression During Fractionated Irradiation
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion
- Status
- UNKNOWN
- Phase
- PHASE2
Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2